First, the adolescent male patient had been receiving oral stanozolol for aplastic anemia over a 6-year consecutive period, during which regular monitoring of liver function revealed abnormalities on several occasions (specifically, persistent fluctuating elevation of ALT/AST since 2020). Here, GPT is linked to aplastic anemia.